Medicare Enrolled
Dr. Milind Parikh, D.O.
Cardiovascular Disease · Chula Vista, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parikh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parikh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parikh
Dr. Milind Parikh is a cardiovascular disease specialist in Chula Vista, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Parikh performed 6,577 Medicare services across 4,049 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parikh received a total of $18,484 from 35 pharmaceutical and/or device companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parikh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 13% volume in CA
$18,484 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,577
Medicare services
Top 13% in CA for cardiovascular disease
4,049
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~548 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
2,224 | $42 | $258 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
1,289 | $196 | $1,614 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
642 | $1 | $20 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
635 | $61 | $262 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
582 | $386 | $1,271 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
286 | $95 | $280 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
233 | $151 | $478 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
201 | $11 | $55 |
| Heart muscle strain imaging | 200 | $33 | $97 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
86 | $97 | $244 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
60 | $21 | $60 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
60 | $774 | $1,946 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $101 | $362 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $143 | $455 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
13 | $87 | $332 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
13 | $15 | $69 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.5% high complexity
75.2% medium
11.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,484
Total received (2018-2024)
Avg $2,641/year across 7 years
Top 18% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
393
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,004 (86.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,268 (12.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$213 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,448
2023
$3,308
2022
$3,737
2021
$4,589
2020
$2,266
2019
$1,021
2018
$116
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,847
HEARTFLOW, INC.
$578
Edwards Lifesciences Corporation
$420
Medtronic, Inc.
$207
Boston Scientific Corporation
$159
Janssen Pharmaceuticals, Inc
$75
Novartis Pharmaceuticals Corporation
$56
Amgen Inc.
$52
Reflow Medical Inc
$30
Novo Nordisk Inc
$25
Top 3 companies account for 82.5% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$6,919
BIOTRONIK INC.
$2,268
Edwards Lifesciences Corporation
$1,610
Boston Scientific Corporation
$1,359
Janssen Pharmaceuticals, Inc
$724
BOSTON SCIENTIFIC CORPORATION
$673
HEARTFLOW, INC.
$578
Medtronic, Inc.
$568
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$559
Shockwave Medical, Inc
$444
Amgen Inc.
$387
Astellas Pharma US Inc
$324
Novartis Pharmaceuticals Corporation
$298
Medtronic Vascular, Inc.
$298
Impulse Dynamics (USA) Inc.
$251
PFIZER INC.
$224
Merck Sharp & Dohme LLC
$129
Biosense Webster, Inc.
$114
Acera Surgical, Inc.
$107
Novo Nordisk Inc
$83
E.R. Squibb & Sons, L.L.C.
$78
ABIOMED
$67
AstraZeneca Pharmaceuticals LP
$62
CVRx, Inc.
$50
Canon Medical Systems USA, Inc.
$41
Merck Sharp & Dohme Corporation
$40
ATRICURE, INC.
$37
Actelion Pharmaceuticals US, Inc.
$34
Kiniksa Pharmaceuticals, Ltd.
$32
Reflow Medical Inc
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Esperion Therapeutics, Inc.
$21
Amarin Pharma Inc.
$20
CARDIVA MEDICAL, INC.
$16
Nevro Corp.
$16
Top 3 companies account for 58.4% of all-time payments
Associated products mentioned in payments ›
AVEIR · AZURE XT DR MRI SURESCAN · Acticor 7 VR-T DX · Arcalyst · Azure · BRILINTA · Barostim Neo System · BioMonitor · CAMZYOS · CONFIRM RX · CardioMEMS HF System · Cardiva VASCADE 6/7F VCS · Carto 3 · Confirm Rx · CoreValve Evolut · CryoConsole · ELIQUIS · EMBLEM · ENSITE · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVERA MRI XT DR SURESCAN · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FFRct · FORTIFY ASSURA · GALLANT · GENERAL TACHY · GENERAL TACHY · GENERAL THERAPIES · GENERAL - TACHY · GENERAL - THERAPIES · General - Therapies · HawkOne · HeartMate 3 Left Ventricular Assist Device · Impella · JARDIANCE · JOT DX · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MERLIN@HOME · MICRA · MITRACLIP · MYLUX · Merlin Connectivity and Remote · Micra · Mitra Clip system · NAVITOR · NEXLETOL · ONYX FRONTIER · OPSUMIT · Optimizer · Ozempic · Quadra Assura CRT Defibrillator · RESONATE · Repatha · Resolute · Restrata Wound Matrix · Reveal LINQ · Rybelsus · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Senza · TOSHIBA SCANNER · UPTRAVI · VARITHENA · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · VersaCross Access Solution · Visia AF · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
198
Per 100K population
6.0
County median income
$102,285
Nearest hospital
SHARP CHULA VISTA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parikh is a cardiac imaging specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement in the top 18% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parikh experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Parikh performed 2,224 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parikh receive payments from pharmaceutical companies?
Yes. Dr. Parikh received a total of $18,484 from 35 companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parikh's costs compare to other cardiologists in Chula Vista?
Dr. Parikh's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parikh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Chula Vista
Browse cardiologists in Chula Vista ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology